Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896843616> ?p ?o ?g. }
- W2896843616 endingPage "15" @default.
- W2896843616 startingPage "6" @default.
- W2896843616 abstract "The aortic valve treatment revolution continues with the maturation of aortic valve repair and the dissemination of transcatheter aortic valve implantation. The recent publication of comprehensive multidisciplinary guidelines for diseases of the thoracic aorta has assigned important roles for the cardiovascular anesthesiologist and perioperative echocardiographer. Although intense angiotensin blockade improves outcomes in heart failure, it might further complicate the maintenance of perioperative systemic vascular tone. Ultrafiltration as well as intensive medical management guided by the biomarker brain natriuretic peptide improves outcomes in heart failure. Continuous-flow left ventricular assist devices have further improved outcomes in the surgical management of heart failure. Major risk factors for bleeding in the setting of these devices include advanced liver disease and acquired von Willebrand syndrome. The metabolic modulator perhexiline improves myocardial diastolic energetics to achieve significant symptomatic improvement in hypertrophic cardiomyopathy. A landmark report was also published recently that outlines the major areas for future research and clinical innovation in this disease. Landmark trials have documented the outcome importance of perioperative cerebral oxygen saturation monitoring as well as the outcome advantages of the Sano shunt over the modified Blalock-Taussig shunt in the Norwood procedure. Furthermore, the development and evaluation of pediatric-specific ventricular assist devices likely will revolutionize the mechanical management of pediatric heart failure. A multidisciplinary review has highlighted the priorities for future perioperative trials in congenital heart disease. These pervasive developments likely will influence the future training models in pediatric cardiac anesthesia. The aortic valve treatment revolution continues with the maturation of aortic valve repair and the dissemination of transcatheter aortic valve implantation. The recent publication of comprehensive multidisciplinary guidelines for diseases of the thoracic aorta has assigned important roles for the cardiovascular anesthesiologist and perioperative echocardiographer. Although intense angiotensin blockade improves outcomes in heart failure, it might further complicate the maintenance of perioperative systemic vascular tone. Ultrafiltration as well as intensive medical management guided by the biomarker brain natriuretic peptide improves outcomes in heart failure. Continuous-flow left ventricular assist devices have further improved outcomes in the surgical management of heart failure. Major risk factors for bleeding in the setting of these devices include advanced liver disease and acquired von Willebrand syndrome. The metabolic modulator perhexiline improves myocardial diastolic energetics to achieve significant symptomatic improvement in hypertrophic cardiomyopathy. A landmark report was also published recently that outlines the major areas for future research and clinical innovation in this disease. Landmark trials have documented the outcome importance of perioperative cerebral oxygen saturation monitoring as well as the outcome advantages of the Sano shunt over the modified Blalock-Taussig shunt in the Norwood procedure. Furthermore, the development and evaluation of pediatric-specific ventricular assist devices likely will revolutionize the mechanical management of pediatric heart failure. A multidisciplinary review has highlighted the priorities for future perioperative trials in congenital heart disease. These pervasive developments likely will influence the future training models in pediatric cardiac anesthesia." @default.
- W2896843616 created "2018-10-26" @default.
- W2896843616 creator A5008942407 @default.
- W2896843616 creator A5012176818 @default.
- W2896843616 creator A5026943594 @default.
- W2896843616 creator A5027546730 @default.
- W2896843616 creator A5030619814 @default.
- W2896843616 creator A5038424228 @default.
- W2896843616 creator A5041080651 @default.
- W2896843616 creator A5045219045 @default.
- W2896843616 creator A5048530076 @default.
- W2896843616 creator A5066327739 @default.
- W2896843616 creator A5079624082 @default.
- W2896843616 date "2011-02-01" @default.
- W2896843616 modified "2023-09-27" @default.
- W2896843616 title "The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights From 2010" @default.
- W2896843616 cites W13264575 @default.
- W2896843616 cites W1585739798 @default.
- W2896843616 cites W162936895 @default.
- W2896843616 cites W1737693309 @default.
- W2896843616 cites W1910579 @default.
- W2896843616 cites W1968286219 @default.
- W2896843616 cites W1971305393 @default.
- W2896843616 cites W1973531661 @default.
- W2896843616 cites W1977427799 @default.
- W2896843616 cites W1981957609 @default.
- W2896843616 cites W198249040 @default.
- W2896843616 cites W1994027246 @default.
- W2896843616 cites W1998062605 @default.
- W2896843616 cites W2006746993 @default.
- W2896843616 cites W2007956679 @default.
- W2896843616 cites W2013845341 @default.
- W2896843616 cites W2015271324 @default.
- W2896843616 cites W2015675455 @default.
- W2896843616 cites W2017785405 @default.
- W2896843616 cites W2018381629 @default.
- W2896843616 cites W2020661424 @default.
- W2896843616 cites W2021752889 @default.
- W2896843616 cites W2023617433 @default.
- W2896843616 cites W2024102644 @default.
- W2896843616 cites W2025297946 @default.
- W2896843616 cites W2026500349 @default.
- W2896843616 cites W2027825713 @default.
- W2896843616 cites W2027847550 @default.
- W2896843616 cites W2028567990 @default.
- W2896843616 cites W2029274030 @default.
- W2896843616 cites W2032054422 @default.
- W2896843616 cites W2033636170 @default.
- W2896843616 cites W2033826302 @default.
- W2896843616 cites W2036738281 @default.
- W2896843616 cites W2037253954 @default.
- W2896843616 cites W2039092900 @default.
- W2896843616 cites W2039683222 @default.
- W2896843616 cites W2041626136 @default.
- W2896843616 cites W2046559951 @default.
- W2896843616 cites W2047697804 @default.
- W2896843616 cites W2049250291 @default.
- W2896843616 cites W2050790735 @default.
- W2896843616 cites W2051193722 @default.
- W2896843616 cites W2064415896 @default.
- W2896843616 cites W2064601111 @default.
- W2896843616 cites W2070182031 @default.
- W2896843616 cites W2070996347 @default.
- W2896843616 cites W2073782555 @default.
- W2896843616 cites W2074974274 @default.
- W2896843616 cites W2075169049 @default.
- W2896843616 cites W2075318595 @default.
- W2896843616 cites W2076830837 @default.
- W2896843616 cites W2076924188 @default.
- W2896843616 cites W2078301727 @default.
- W2896843616 cites W2079492007 @default.
- W2896843616 cites W2084489610 @default.
- W2896843616 cites W2087248947 @default.
- W2896843616 cites W2092322834 @default.
- W2896843616 cites W2096732105 @default.
- W2896843616 cites W2101726024 @default.
- W2896843616 cites W2103423712 @default.
- W2896843616 cites W2105057339 @default.
- W2896843616 cites W2105138814 @default.
- W2896843616 cites W2105789979 @default.
- W2896843616 cites W2107336378 @default.
- W2896843616 cites W2115445997 @default.
- W2896843616 cites W2119905735 @default.
- W2896843616 cites W2124400870 @default.
- W2896843616 cites W2126242677 @default.
- W2896843616 cites W2128702089 @default.
- W2896843616 cites W2132607402 @default.
- W2896843616 cites W2133069465 @default.
- W2896843616 cites W2137816391 @default.
- W2896843616 cites W2140116078 @default.
- W2896843616 cites W2142387793 @default.
- W2896843616 cites W2149609916 @default.
- W2896843616 cites W2156469127 @default.
- W2896843616 cites W2165719156 @default.
- W2896843616 cites W2168297810 @default.
- W2896843616 cites W2466879592 @default.
- W2896843616 cites W2896219306 @default.
- W2896843616 cites W2897097911 @default.